Molecular Basis for Recognition of an Arthritic Peptide and a Foreign Epitope on Distinct MHC Molecules by a Single TCR1

KRN TCR transgenic T cells recognize two self-MHC molecules: a foreign peptide, bovine RNase 42–56, on I-Ak and an autoantigen, glucose-6-phosphate isomerase 282–294, on I-Ag7. Because the latter recognition event initiates a disease closely resembling human rheumatoid arthritis, we investigated the structural basis of this pathogenic TCR’s dual specificity. While peptide recognition is altered to a minor degree between the MHC molecules, we show that the receptor’s cross-reactivity critically depends upon a TCR contact residue completely conserved in the foreign and self peptides. Further, the altered recognition of peptide derives from discrete differences on the MHC recognition surfaces and not the disparate binding grooves. This work provides a detailed structural comparison of an autoreactive TCR’s interactions with naturally occurring peptides on distinct MHC molecules. The capacity to interact with multiple self-MHCs in this manner increases the number of potentially pathogenic self-interactions available to a T cell.

[1]  A. Smolyar,et al.  The crystal structure of a T cell receptor in complex with peptide and MHC class II. , 1999, Science.

[2]  C. Benoist,et al.  Arthritis provoked by linked T and B cell recognition of a glycolytic enzyme. , 1999, Science.

[3]  E. Unanue,et al.  The lack of consensus for I-A(g7)-peptide binding motifs: is there a requirement for anchor amino acid side chains? , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[4]  K. Wucherpfennig,et al.  pH-dependent Peptide Binding Properties of the Type I Diabetes–associated I-Ag7 Molecule: Rapid Release of CLIP at an Endosomal pH , 1999, The Journal of experimental medicine.

[5]  P. Allen,et al.  A Kinetic Threshold between Negative and Positive Selection Based on the Longevity of the T Cell Receptor–Ligand Complex , 1999, The Journal of experimental medicine.

[6]  K. Rajewsky,et al.  From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins. , 1999, Immunity.

[7]  E. Appella,et al.  Structural Evidence of  T Cell Xeno-reactivity in the Absence of Molecular Mimicry , 1999, The Journal of experimental medicine.

[8]  R. Dwek,et al.  Crystal structures of two H-2Db/glycopeptide complexes suggest a molecular basis for CTL cross-reactivity. , 1999, Immunity.

[9]  Hiroaki Ito,et al.  Analysis of the Role of  Variation of Major Histocompatibility Complex Class II Expression on Nonobese Diabetic (NOD) Peripheral T Cell Response , 1998, The Journal of experimental medicine.

[10]  P. Allen,et al.  A basis for alloreactivity: MHC helical residues broaden peptide recognition by the TCR. , 1998, Immunity.

[11]  P. A. Peterson,et al.  Structural basis of 2C TCR allorecognition of H-2Ld peptide complexes. , 1998, Immunity.

[12]  W A Hendrickson,et al.  Crystal structure of I-Ak in complex with a dominant epitope of lysozyme. , 1998, Immunity.

[13]  P. A. Peterson,et al.  Crystal structures of two I-Ad-peptide complexes reveal that high affinity can be achieved without large anchor residues. , 1998, Immunity.

[14]  L R Pease,et al.  Structural basis of plasticity in T cell receptor recognition of a self peptide-MHC antigen. , 1998, Science.

[15]  E. Unanue,et al.  Autoreactivity of T cells from nonobese diabetic mice: an I-Ag7-dependent reaction. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[16]  D. Covell,et al.  Differential contact of disparate class I/peptide complexes as the basis for epitope cross-recognition by a single T cell receptor. , 1997, Journal of immunology.

[17]  V. Kouskoff,et al.  Organ-Specific Disease Provoked by Systemic Autoimmunity , 1996, Cell.

[18]  K. Wiesmüller,et al.  Molecular basis for the recognition of two structurally different major histocompatibility complex/peptide complexes by a single T-cell receptor. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[19]  E. Unanue,et al.  A negatively charged anchor residue promotes high affinity binding to the MHC class II molecule I-Ak. , 1996, Journal of immunology.

[20]  E. Unanue,et al.  Appreciating the Complexity of MHC Class II Peptide Binding: Lysozyme Peptide and I‐Ak , 1996, Immunological reviews.

[21]  P. Allen,et al.  Endogenous altered peptide ligands can affect peripheral T cell responses , 1996, The Journal of experimental medicine.

[22]  E. Unanue,et al.  The class II MHC I-Ag7 molecules from non-obese diabetic mice are poor peptide binders. , 1996, Journal of immunology.

[23]  L. Pease,et al.  Alloreactive 2C T cells recognize a self peptide in the context of the mutant Kbm3 molecule. , 1995, Journal of immunology.

[24]  M. González-Gay,et al.  Could HLA-DRB1 be the protective locus in rheumatoid arthritis? , 1995, Immunology today.

[25]  J. Rothbard,et al.  Specific T cell recognition of minimally homologous peptides: evidence for multiple endogenous ligands. , 1995, Immunity.

[26]  J. Freed,et al.  Comparison of peptides bound to spleen and thymus class II , 1993, The Journal of experimental medicine.

[27]  C. Weyand,et al.  The Influence of HLA-DRB1 Genes on Disease Severity in Rheumatoid Arthritis , 1992, Annals of Internal Medicine.

[28]  R. Winchester Genetic Determination of Susceptibility and Severity in Rheumatoid Arthritis , 1992, Annals of Internal Medicine.

[29]  S. Hedrick,et al.  Involvement of the same region of the T cell antigen receptor in thymic selection and foreign peptide recognition. , 1992, Journal of immunology.

[30]  C. Benoist,et al.  Delineation of antigen contact residues on an MHC class II molecule. , 1990, The EMBO journal.

[31]  R. Holmdahl,et al.  Structures on the I‐A molecule predisposing for susceptibility to type II collagen‐induced autoimmune arthritis , 1990, European journal of immunology.

[32]  P. Allen,et al.  Reconstruction of the immunogenic peptide RNase(43-56) by identification and transfer of the critical residues into an unrelated peptide backbone , 1989, The Journal of experimental medicine.

[33]  D. Stage,et al.  HLA genes associated with rheumatoid arthritis. Identification of susceptibility alleles using specific oligonucleotide probes. , 1989, Arthritis and rheumatism.

[34]  David M. Kranz,et al.  Positive and negative selection of an antigen receptor on T cells in transgenic mice , 1988, Nature.

[35]  J. Todd,et al.  A molecular basis for MHC class II--associated autoimmunity. , 1988, Science.

[36]  M. A. Saper,et al.  The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens , 1987, Nature.

[37]  M. Gurney,et al.  Molecular cloning and expression of neuroleukin, a neurotrophic factor for spinal and sensory neurons. , 1986, Science.

[38]  H. Grey,et al.  Antigen recognition by H-2-restricted T cells. I. Cell-free antigen processing , 1983, The Journal of experimental medicine.

[39]  C. Werning [Rheumatoid arthritis]. , 1983, Medizinische Monatsschrift fur Pharmazeuten.

[40]  J. Dausset GENETICS OF THE MAJOR HISTOCOMPATIBILITY COMPLEX , 1976 .

[41]  S. Paget,et al.  Predominantly T-cell infiltrate in rheumatoid synovial membranes. , 1975, The New England journal of medicine.